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Cisplatin (Csp) is a recurrently used chemotherapeutic drug but its use is inadequate due to undesirable adverse effects. 
In search of alternative medicine more attention has been given to phytochemicals. Septilin (Spt), a polyherbal drug and its 
therapeutic potential is huge but there is a scarcity of studies on its cytotoxic potential on cancer cells. The current study was 
designed to examine the effects of Spt in combination with Csp on human breast adenocarcinoma (MCF-7) and normal 
human breast epithelial (MCF-10A) cell lines. Cell viability for Spt treated cells was studied using MTT assay. IC50 value of 
Csp on MCF-7 cells was found to be 10 µg/mL at 24 h. This dose was further used to study the combined effects of Csp 
with Spt on MCF-7 and MCF-10A cell lines. Maximum cytotoxicity of Spt on MCF-7 cells was observed at Spt 5 µg/mL. 
The mechanism of Spt induced cytotoxicity was studied using apoptosis assay. Spt did not show any cytotoxic effects on 
MCF-10 A normal human breast epithelial cells, indicating Spt has no effect on normal cells. Our findings suggest that Spt can be 
used in combination with an anticancer drug Csp to increase its efficacy and/or to minimize its side effects on normal cells. 
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Breast cancer is one of the major causes of morbidity 
and mortality among women worldwide1,2. Csp is 
among the most effective chemotherapeutic drugs 
widely used to treat ovarian, testicular, breast, 
bladder, neck, lung, sarcomas, blood vessels and bone 
cancers3,4. In cancer cells, the cytotoxicity of DNA 
alkylating agent Csp is due to the formation of 
adducts and inter/intrastrand cross links. Because of 
drug resistance and side effects other platinum-
containing chemotherapeutic drugs like carboplatin, 
nedaplatin, oxaliplatin and others have also been 
used5. Csp is also used in combination with natural 
agents such as osthol, honey bee venome, anvirzel, 
vinblastine and bleomycin to produce synergistic or 
additive effects in death of cancer cells, without 
causing undesirable effects on normal cells6. 
Chemotherapy, radiotherapy, hormone therapy, 
immune therapy and surgery are found to be an 
effective modality for cancer treatment and 
prevention7,8. Due to the side effects of conventional 
cancer treatment therapies, it is necessary to search 
newer effective chemotherapeutic agent with potent 
activity and minimal side effects9. In recent days, 
more importance has been given for plant derived 
components as pharmacological agents. Plant based 
components are rich in nutritional and medicinal 
value10. Septilin is an ayurvedic herbo-mineral 
preparation from himalaya herbal health care, 
consisting of extracts and powders from 
Maharasanadi qoath, Tinospora cordifolia, Rubia 
cordifolia, Glycyrriza glabra, Emblica officinalis, 
Moringa pterigosperma (Moringa oleifera), 
Balsamodendron mukul and Shankha bhasma11. In the 
conventional health practices, Spt is being used as 
antibacterial, anti-inflammatory and as an 
immunomodulator. The herbal constituents of Spt are 
rich in phytochemicals including tannin, sugars, 
alkaloids, flavonoids and proteins12. Our previous 
study gave some insight into the protective effects of 
Spt against an anticancer agent cyclophosphamide 
induced cytogenetic damage on mice bone marrow 
cells13. Based on the earlier reports available on the 
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pharmacological activities of Spt, prompted us to 
evaluate its cytotoxic effects and possible mechanism 
in induction of cell death in human breast 
adenocarcinoma cells. 
 
Materials and methods 
Chemicals  
Spt, procured from the Himalayan drug company, 
India (Batch No.- 37301126B), was prepared in 
Dulbecco’s Modified Eagle medium (DMEM).  
Csp (Lot No.: MKBN7276V), 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl tetrazolium bromide (MTT), 
Dimethyl sulfoxide (DMSO), Ethidium bromide 
(EtBr) and Acridine orange (AO) were obtained from 
Sigma-Aldrich, (USA). DMEM, Fetal bovine serum 
(FBS) and Gentamycin were acquired from HiMedia, 
India.  
 
Cell line and cell culture 
MCF-7 and MCF-10A cell lines were obtained 
from National Centre for Cell Sciences (NCCS; Pune, 
India) and stock cultures were preserved in liquid 
nitrogen. Cells were cultured in 75 cm2 flasks 
containing DMEM supplemented with 10% FBS, 
0.15% sodium bicarbonate, 2.5 mL of antibiotic-
antimycotic solution and 2 mL of gentamycin  
(80 μg/mL) and incubated in 5% CO2 (95% humidified 
air) at 37⁰C (NuAire, Plymouth, MN, USA).  
 
Assessment of cytotoxicity - MTT assay  
The cytotoxicity of Csp and Spt on MCF-7 and 
MCF-10A cells was measured using MTT assay as 
per the method described by Mosmann14. Concisely, 
cells at density of 5×103 cells (100 µL/well) were 
seeded in 96-well plates and incubated at 37⁰C in 5% 
CO2 for 24 h. After incubation, the medium was 
replaced with the medium containing varying 
concentration of Csp (1.0, 2.5, 5.0, 10 and 20 μg/mL) 
and Spt (0.5, 1.0, 2.5, 5.0 and 10 μg/mL). After 24 h 
of the treatment, cells were washed with phosphate 
buffered saline (PBS) and incubated for 4 h with  
20 𝜇L (1 mg/mL) of MTT at 37⁰C. The formazon 
crystals formed in each well after incubation were 
dissolved in 100 𝜇L of DMSO and absorbance was 
read at 570 nm using multi well spectrophotometer 
(Tecan, Austria). Each treatment was completed in 
triplicates and cell viability was calculated. The 
percentage of viable cells were used to determine the 
IC50 value, which is the concentration of Csp 
inhibiting 50% of MCF-7 cell growth compared with 
that of untreated cells (GraphPad Software, Inc., CA, 
USA). The obtained IC50 value of Csp was further 
used for combined treatment studies. 
 
Apoptosis assay 
Morphological changes in cells were determined by 
employing AO/EtBr dual staining method. For 
apoptotic assay, exponentially growing cells were 
seeded at the density of 106/plate in 6 cm plates and 
incubated at 37⁰C in a 5% CO2 atmosphere for 24 h. 
After incubation, media was aspirated and cells were 
treated with Csp (10 μg/mL) and Spt (5 μg/mL) and 
incubated for 24 h. After incubation, cells were 
collected by centrifugation at 1000 rpm for 5 min. 
Collected cells were washed with PBS and stained 
with AO/EtBr (1:1 v/v) dye. 100 stained cells from 
each treatment group were scored under fluorescence 
microscope at 400 X magnification and were 
classified as live cells (L), early apoptotic cells (EA), 
late apoptotic cells (LA) and necrotic cells (N) as per 
the method of Aithal et al.,10. Live cells have intact 
plasma membrane and hence, allow only AO to enter 
them which makes their nuclei fluoresce green under 
microscope. EtBr can only permeate if cell membrane 
integrity is lost; therefore, EA, LA and N cells were 
observed under fluorescence microscope as 
condensed yellowish-green nuclei, condensed red 
nuclei and as red nuclei respectively. 
 
Statistical analysis 
Statistical significance of the data was analysed by 
employing one way ANOVA and Dunnett’s post hoc 
tests using Graph Pad Prism 5 (GraphPad Software, 
Inc., CA, USA) and data were expressed as mean±SE. 
Differences with a p-value of 0.05 or lower were 
considered to be statistically significant. Significance 
of obtained results were designated by p<0.05 
(significant), p<0.01 (very significant) and p<0.001 




In MCF-7 cells treated with Csp, a concentration 
dependent decrease in the viability of cells was 
observed. An IC50 value of Csp on MCF- 7 cells at  
24 h time interval was found to be 10 µg/mL (Fig. 1). 
The cytototoxic potential of Spt on MCF-7 cells at  
24 h treatment interval was also studied. In MCF-7 
cells were treated with varying concentrations of Spt 
(0.5, 1.0, 2.5, 5.0 and 10 µg/mL), a dose dependent 
reduction in the viability of human breast 
adenocarcinoma cells at all treatments was noticed. 




Spt at a concentration of 10 µg/mL on MCF-7 cells 
have shown 20.9% growth inhibition. In combined 
treatment groups, the maximum growth inhibition of 
MCF-7 cells (72.4%) was noticed at Spt  
5 µg/mL+Csp 10 µg/mL concentration. The response 
of Spt on MCF-7 cells is clearly shown in Table 1 & 
Fig. 2.  
Non-cancerous MCF-10A cells were also treated 
with media containing different concentrations of Spt 
(0.5, 1.0, 2.5, 5.0 and 10 µg/mL). Spt did not show 
any cytotoxic effects on normal MCF-10A cells, on 
the other hand increase in the proliferation of normal 
cells in a concentration dependent manner. Results 
indicated that, MCF-10A cells were less susceptible 
to the actions of the Spt. Spt in combination with Csp 
have minimised the toxic effect of Csp on normal 
cells and is evident by increased MCF-10A cell 
viability in combined treatment groups. However, the 
maximum inhibition of Csp induced cell toxicity on 
normal breast epithelial cells was observed at Spt  
5 µg/mL concentration (p<0.001). Fig. 3 illustrates 
the cytoprotective effect of Spt on MCF 10A cells 
against Csp induced cytotoxicity  
 
Apoptosis assay 
Apoptosis assay was performed to determine the 
apoptotic morphological changes induced by Spt and 
Csp on MCF-7 and MCF-10A cells using AO/EtBr 
staining method. The nuclei of untreated control cells 
were stained with acridine orange and were appear to 
be intact green in colour (Fig. 4 A). The cells treated 
with Csp (10 µg/mL), showed the presence of EA,  
LA and N cells with fragmented nuclei (Fig. 4 C).  
The results of AO/EtBr double stained MCF-7 cells 
treated with Csp and Spt at 24 h are shown in Fig. 5. 
In which, the apoptotic morphological changes 
induced by Csp and Spt were expressed in percentage. 
As indicated in figure it is clear that, in MCF-7 cells 
treated with Csp (10 µg/mL) live cells percentage was 
found to be decreased with gradual increase in the 
percentage of necrotic cells. Spt (5 µg/mL) treatment 
decreased the number of viable MCF-7 cells (p<0.01) 
without increasing the frequency of necrotic cells 
 
 
Fig. 1 — An IC50 curve for MCF-7 cells treated with cisplatin at 
24 h. (IC50 value–10 µg/mL) 
 
Table 1 — Effect of septilin and cisplatin on MCF-7 cells at 24 h 
Concentration 
 (μg/mL) 
% MCF-7 cell inhibition 
Spt Spt+Csp (10 µg/mL) 
 0.5 4.31±0.012 55.4±0.487 
 1.0 4.62±0.058 60.9±0.796 
 2.5 5.49±0.069 67.0±0.198 
 5.0 10.1±0.080 72.4±0.731 
 10.0 20.9±0.096 69.5±0.986 
Values are mean±SE, (n=3).  
 
 
Fig. 2 — Effect of septilin and cisplatin on MCF-7 cell viability. 
Values are mean±SE, (n=3), One way ANOVA followed by
Dunnett’s post hoc test; ap<0.001 compared to control cells,
bp<0.05 compared to control cells, cp<0.01 compared to control 
cells dp<0.001 compared to Csp treated cells, ep<0.05 compared to 




Fig. 3 — Effect of septilin and cisplatin on MCF-10A cell viability. 
Values are mean±SE, (n=3), ap<0.001 compared to control cells,
bp<0.01 compared to control cells, cp<0.05 compared to Csp treated 
cells, dp<0.01 compared to Csp treated cells. 
 




stained with red colour, when compared to Csp 
treated cells. Thus indicating, MCF-7 cell death 
occurred primarily through apoptosis rather than 
necrosis. These results are in agreement with the 
results of MTT assay showing the cytotoxic potential 
of Spt on human breast adenocarcinoma cells. 
MCF-10A cells treated with Spt (5 µg/mL) did not 
show any nuclei morphological alteration compared 
to untreated control cells (p<0.001). Spt (5 µg/mL) 
enhanced the growth of normal breast epithelial cells 
as noticed by increased number of viable normal cells. 
MCF-10A cells treated with Csp revealed the 
presence of more number of early apoptotic, late 
apoptotic and necrotic cells when compared to 
untreated control MCF-10A cells (p<0.001). Spt  
(5 µg/mL) in combination with Csp (10 µg/mL) 
protected the normal MCF-10A cells against the 
cytotoxic effects of Csp significantly (p<0.001) 
compared to Csp alone treated cells (Fig 6).  
 
 
Fig. 6 — Percentage of viable, apoptotic and necrotic MCF-10A 
cells treated with septilin and cisplatin. Values are in mean±SE, 
(n=3), 100 cells scored from each treatment group. One way 
ANOVA followed by Dunnett’s post hoc test; ap<0.001 compared 
to control cells, bp<0.001 compared to Csp treated cells. cp<0.01 
compared to Csp treated cells. L - Live cells; EA - Early apoptotic 
cells; LA - Late apoptotic cells; N - Necrotic cells. 
 
Discussion 
Csp is anticancer medication used to treat breast, 
ovarian, lung and neck cancer. Improving the efficacy 
of Csp is crucial for the survival of malignancy 
patients. Csp targets the cancerous cells through 
inducing cytotoxic effects however; some side effects 
can also be seen on normal cells15,9,16. In the present 
study, 24 h after the treatment of MCF-7 cells with 
Csp showed decrease in the percentage of viable cells 
in a dose dependent manner and is evident by the 
results of MTT assay (Fig. 1). Csp induced 
cytotoxicity on cancerous cells is may be due to the 
activation of extracellular stress response mitogen 
activated protein kinase (MAPK) cascade pathway. 
This pathway is important for cytotoxic action of 
Csp17. As we evaluated, the concentration of Csp 
required to inhibit 50% growth of MCF-7 cells was 
found to be 10 µg/mL (Fig. 1). Csp not only showed 
its cytotoxicity towards cancer cells but also, it 
showed its cytotoxicity on normal breast epithelial 
cells. In clinical practice, Csp is frequently given with 
other chemotherapeutic drugs to enhance the efficacy 
of Csp on killing cancerous cells6,18. Synergy between 
two or more drugs enhances the cytotoxic effect of 
Csp19. 
Now a days, interest in natural compound has been 
grown due to the cost and side effects of 
conventionally used pharmacological drugs like 
Csp20,21. The bioactive compounds with known 
antiproliferative and antioxidant activities can be used 
in combination with Csp to enhance its cytotoxic 
effect on cancerous cells without affecting the growth 
 
 
Fig. 4 — Nuclear morphological alterations in MCF-7 cells induced
by septilin and cisplatin assessed using AO/EtBr staining A.
Untreated control cells Live cells (L); B. Spt (5 µg/mL) treated cells
showing more early apoptotic cells; C. Csp (10 µg/mL) treated cells




Fig. 5 — Percentage of viable, apoptotic and necrotic MCF-7 cells
treated with septilin and cisplatin. Values are in mean±SE, (n=3),
100 cells scored from each treatment group. One way ANOVA
followed by Dunnett’s post hoc test; ap<0.001 compared to
control cells, bp<0.01 compared to control cells, cp<0.05
compared to Csp treated cells, dp<0.01 compared to Csp treated
cells. L - Live cells; EA - Early apoptotic cells; LA - Late
apoptotic cells; N - Necrotic cells. 
 




of normal cells. In line of this, recently Mirmalek et al.,22 
compared the cytotoxic effects of hypercin and Csp 
on MCF-7 cells. Hypercin, a bioactive compound and 
its concentration needed for 50% inhibition of MCF-7 
cells was found to be less compared to Csp. In our 
study, to evaluate the cytotoxic potential of Spt on 
human breast adenocarcinoma cell line we carried out 
the MTT assay. Spt is a polyherbal drug formulation 
and in our study it displayed its mild cytotoxic  
effect on MCF-7 cells. Even if, there is no much  
anti-proliferative effect of Spt alone on MCF-7 cells 
but, Spt in combination with Csp have showed their 
modulatory effect on Csp cytotoxicity in MCF-7 cells. 
Spt enhanced the efficacy of Csp on cancerous cells. 
The maximum MCF-7 cell inhibition by Spt  
(5 µg/mL) in combination with Csp was found to be 
72.4% (Table 1). Also, Spt have shown its distinctive 
mode of action on cancerous and normal cells. As 
indicated in Fig. 3, Spt enhanced the proliferation of 
MCF-10A cells in a dose-dependent manner. The 
cytoprotective effect of Spt on MCF-10A cells was 
also noticed in combination of Csp wherein, it 
provided significant protection against the toxic 
effects induced by Csp on normal cells at all the 
concentration tested. The increased viability of 
normal breast epithelial cells treated with Spt suggests 
its different way of action on normal and cancerous 
cells. Consistently with the above conclusion,  
Omar et al.,23 reported the antiproliferative and 
synergistic effects of bee pollen extract in 
combination with Csp on MCF-7 cell line and L929 
normal cell lines. The solvent extracts of bee pollen 
extracts showed its antiproliferative effects only on 
cancer MCF-7 cells devoid of causing any cytotoxic 
effect on normal L929 cells. The differential effects of 
bee pollen extract on cancer and normal cells indicate 
its specificity towards cancer cells. 
Based on the earlier reports available on the plant 
constituents of Spt, the possible cytotoxic effect 
offered by Spt is may be because of the presence of 
phytochemicals such as phenolics, tannins, saponins 
and terpenoids. There are few supporting reports on 
cytotoxicity of the plant components of Spt on MCF-7 
cell lines. M. oleifera showed its cytotoxicity on 
MCF-7 cells as evident by reduction in number of 
viable cells compared to vehicle control group. The 
cytotoxic activity of this plant may be due to the 
existence of seed essential oil24. Rahaman et al.,25 also 
revealed the cytotoxic potential of M. oleifera seed 
and leaf extract on MCF-7 cells with reduction in 
viable cells. The presence of Glucosinolates (sulphur 
containing) compound in M. oleifera was ascribed for 
this effect. β-glycyrrhetic acid a bioactive component 
present in the Glycyrrhiza glabra may attributed for 
its cytotoxic activity against MCF-7 cells26. Aqueous 
and hydro-alcoholic extracts of T. cordifolia induced 
the degenerative morphological changes in the MCF-
7 cells27. Kumari and Jesudas,28 evaluated the 
cytotoxic and anticancer potential of T. cordifolia 
against MCF-7 cells and this study revealed that, the 
presence of phenolic components in this plant was 
responsible for its antiproliferative potential. 
To understand the mechanism of cytotoxicity or 
cell death induced by Csp and Spt on cancer cells 
apoptosis assay was used. Apoptosis is one of the 
important genetically regulated programmed cell 
death that eradicates the physically damaged and 
abnormal cells. Cell death occurs either by apoptosis 
or necrosis. However, apoptosis was found to be more 
favourable because it does not trigger inflammatory 
response. In in vitro condition, due to lack of 
macrophages apoptotic cells will not be phagocytized 
instead cells undergo nuclear morphological changes 
and will be lysed. The effectiveness of anticancer 
drugs is measured by their ability to identify the 
cancer cells and to stimulate apoptosis29. Apoptosis is 
reported as one of the important mechanisms through 
which plants and bioactive compounds mediates 
anticancer effects30. 
In the present study, AO/EtBr dual staining method 
was followed to assess the mechanism of cytotoxicity 
induced by Spt and Csp on MCF-7 cells. In the 
AO/EtBr dual staining method, MCF-7 and MCF-10A 
cells treated with Csp showed increase in the 
percentage of necrotic cells in contrast to untreated 
control cells (Fig. 2). Also, it revealed the  
presence of cells with membrane blebbing, chromatin 
condensation and fragmentation (Fig. 4C). Csp 
induced apoptosis or necrosis is due the overload of 
intracellular reactive oxygen species. Csp is an 
alkylating agent and this kind of anticancer drug 
induces apoptosis/necrosis through oxidative stress 
mediated mechanism10 Spt treatment augmented the 
cytotoxic effect of Csp on MCF-7 cells by increasing 
the percentage of early and late apoptotic cells 
compared to Csp treated cells (p<0.001). The 
reduction in the number of viable MCF-7 cells and 
presence of morphological apoptotic changes in the 
cells treated with Spt in combination with Csp 
indicates the cytotoxic and apoptotic potential of Spt 




on human adenocarcinoma cells (Fig. 3). Cell death 
induced by Spt followed the sequence of early and 
late apoptotic morphological changes, representing 
cell death induced by Spt is through apoptotic 
pathway rather than necrotic (Fig 4B). This result is 
consistent with previous observations done by  
Ho et al.,31 in which vanillin, a bioactive compound 
induced apoptotic pathway mediated cell death on 
human colorectal cancer cells.  
The mechanism of action of Spt on MCF-7 cancer 
cells is not known however; earlier report had 
suggested that, plant extract induced apoptosis may be 
due to activation of several cellular pathways 
participating in induction of apoptotic and necrotic 
cells. This conclusion was supported by the work 
done by Padma et al.,32 in which, mangiferin a natural 
polyphenol component induced apoptosis in 
rhabdomyosarcoma cells was through sustained 
oxidative stress. Cytotoxic and apoptotic effect of 
Flueggea leucopyrus on human endometrial 
carcinoma cells was due to imbalance between 
oxidative stress and antioxidant status30. Bhavana et al.33 
showed potential of Croton bronplandianus leaf 
extract induced apoptotic mediated cytotoxicity on 
lung cancer cell line A549. The polyphenolic 
compound present in this leaf extract induced the 
apoptosis in cancer cells by activating series of 
signalling pathway linked to apoptosis. Behzad et al.34 
revealed the cytotoxic and apoptotic potential of 
Primula auriculata extract on HT-29 human colon 
adenocarcinoma cells, the presence of phenolic 
compounds like flavonoids and saponins may 
attributed for its cytotoxic and apoptotic effects. 
Based on the above observations the possible 
apoptotic effect of Spt on MCF-7 cells is may be due 
to the enhanced oxidative stress and due to prooxidant 
activity of phytochemicals present in it. 
 
Conclusion 
The current study determined the potential role of 
Spt in enhancing the efficacy of Csp induced 
cytotoxicity on human breast adenocarcinoma cells 
without inducing any cytotoxic effect on normal 
breast epithelial cells. The current findings also 
highlight that, Spt induced cytotoxicity on cancer 
cells is through normal apoptosis mechanism rather 
than necrotic pathway. In view of the present 
findings, Spt can be used in chemotherapy treatment 
as an adjuvant to enhance the efficacy of Csp. Further 
studies may require to determine the molecular 
mechanism underlying the observed cytotoxic effects 
of Spt with Csp on cancerous cells. 
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